Study of linvemastat for partially controlled Type 2 asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests an experimental pill (linvemastat) for people with partially controlled Type 2 asthma. The goal is to see if it can improve asthma control and reduce the risk of asthma attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old.
- Your doctor has confirmed you have Type 2 high asthma (a specific type of asthma).
- You have been using at least a medium-dose steroid inhaler combined with a long-acting beta-agonist (LABA) for at least 90 days, with a stable dose for the last month.
- Your symptoms are not fully controlled (score of 1.5 or higher on the ACQ test).
- Your lung function is between 40% and 80% of the expected value for your age and height.
- You have had at least one serious asthma attack (needing steroids, ER, or hospital) in the last 2 years.
- You are not a current smoker and haven't quit within the last 6 months, and you don't have a heavy smoking history (more than 10 pack-years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called CM326 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if CM326 can help reduce asthma attacks and improve breathing.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study tests CM310 to see if it can improve asthma in people with moderate to severe asthma who are still having uncontrolled symptoms and severe flare-ups despite regular inhaler treatment. You may be eligible if your lung function and asthma control tests fit the study limits and you’ve had a recent severe exacerbation.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.